|
gptkbp:instance_of
|
gptkb:Company
|
|
gptkbp:bfsLayer
|
7
|
|
gptkbp:bfsParent
|
gptkb:Encarnación_Airport
gptkb:Seattle_Genetics
|
|
gptkbp:acquisition
|
gptkb:Kite_Pharma
gptkb:Agenus_Inc.
|
|
gptkbp:awards
|
Best Places to Work
Innovative Company Award
Top 100 Biopharma Companies
Top 10 Biotech Companies
Best Workplaces in Boston
|
|
gptkbp:ceo
|
Dr. John Maraganore
|
|
gptkbp:clinical_trial
|
ongoing
|
|
gptkbp:collaborations
|
gptkb:healthcare_organization
gptkb:Duke_University
gptkb:Johns_Hopkins_University
gptkb:University_of_Washington
gptkb:Fred_Hutchinson_Cancer_Research_Center
|
|
gptkbp:employees
|
approximately 1,500
|
|
gptkbp:focus_area
|
gptkb:healthcare_organization
gptkb:vaccine
antibody-drug conjugates
|
|
gptkbp:founded
|
gptkb:1992
|
|
gptkbp:founder
|
Dr. John Maraganore
|
|
gptkbp:headcount
|
1,500 (2021)
|
|
gptkbp:headquarters
|
gptkb:Cambridge,_Massachusetts
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
SGEN
|
|
gptkbp:industry
|
gptkb:Company
|
|
gptkbp:key_people
|
Dr. John Maraganore
|
|
gptkbp:market_cap
|
$25 billion (2021)
|
|
gptkbp:partnership
|
gptkb:Takeda_Pharmaceutical_Company
gptkb:Pfizer
|
|
gptkbp:philanthropy
|
Education programs
Cancer research funding
Diversity and inclusion initiatives
Community health initiatives
Employee volunteer programs
|
|
gptkbp:products
|
gptkb:Tukysa
gptkb:Adcetris
biopharmaceuticals
Padcev
|
|
gptkbp:research_focus
|
oncology
hematology
solid tumors
|
|
gptkbp:revenue
|
$1.5 billion (2020)
|
|
gptkbp:subsidiary
|
gptkb:Kite_Pharma
gptkb:Agenus_Inc.
Seattle Genetics, Inc.
|
|
gptkbp:traded_on
|
gptkb:NASDAQ
|
|
gptkbp:website
|
www.sgen.com
|